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auditable dataset for lung cancer patients. An RTT and the 
chair of radiation oncology consulted on four occasions over 3 
months, and then consulted on a further 4 occasions over 6 
weeks in conjunction with a clinical research fellow. 
Results: The consultations begun with a loose outline based 
on the journey of the patient from initial diagnosis, through 
methods of biopsy and histological classification, 
encompassing chemotherapy, surgery, and radiotherapy 
treatment. Full medical history and relevant functional 
analysis results give a full background and are included in 
pre-defined scores for associated co-morbidities, and 
dyspnoea, both of which are excellent prognostic indicators. 
Details of diagnostic, planning, on treatment and follow up 
imaging are linked into the current version. All radiotherapy 
plan data, and treatment parameters are included with links 
to volumetric imaging providing an excellent research 
resource. An auditable defined dataset for lung cancer 
patients is now available, and will begin collecting data for 
lung patients in April 2015, pending approval from the Site 
Reference Group and the employment of a team to collect, 
input and quality control the dataset. This dataset will be 
manually collected, and consultations have already begun to 
develop an electronic version which will automatically 
populate information where applicable. 
Conclusions: The RTT has a valuable role to play in the 
definition of functional datasets collected for research 
purposes. The value of the collection and maintenance of 
such databases, and their interaction with other electronic 
systems will become more and more important as the data 
we create, and the evidence we can see drives forward 
changes in practice. 
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Purpose/Objective: Within our Quality Management Program 
(QMP) we implemented a daily peer review round (PRR) to 
validate RT plans prior to treatment commencement (or 
within the first fractions). The purpose of this study is to 
report the outcomes of these rounds and to show how these 
outcomes are used for quality monitoring and improvement. 
Materials and Methods: Following our QMP all patients but 
urgent indications should be presented to the PRR. All 
radiation oncologists (RO) (8), RO residents, 1 Medical 
Physicist (MP) and 1 MP resident participate in the rounds. 
The data presented were collected over a year. A total of 
1391 patients started EBRT treatment. Patient history data 
and images were presented and the treatment indication, 
dose prescription, volume delineation and the dose 
distribution were reviewed. Details of proposed changes were 
collected prospectively within a data-base together with 
tumour site, date of CT-planning and starting treatment 
date. From this data-base several Quality Indicators (QI) were 
defined and are shown in table I. The data were collected 
daily and the results were analysed yearly. The data-base 
allows stratifying all QI by tumour site and technique (3DCRT, 
IMRT or SBRT) as it was done for this study.  
Results: Of the 1391 eligible patients, 801 (58%) were 
presented for peer review. Fig. shows an increase of 
reviewed patients after March because a time slot on Friday 
was blocked to review the cases that had not been presented 
during the week. At least 4/8 radiation oncologists 
participated in 67% of the patient reviews. Table 1 shows the 
results of QI analysed over a year. The number of cases 
requiring changes is similar to those reported by other groups 
performing QA rounds. The higher number of changes is 
linked to volume contouring (4.5%) while the number of cases 
requiring re-planning due to a suboptimal dose distribution is 
significantly lower (1.5%). This is related to the fact that 
while volume delineation is not reviewed by an independent 
RO before starting dose planning, treatment plan and dose 
distribution is performed by a radiation technologist, 
reviewed by a MP and discussed with the RO before being 
presented in the peer review round. The changes were 
stratified by location and technique; however no prevalence 
of one site or a technique could be detected. The time 
between planning CT and start of treatment is within the 
standards set by our department, except for palliative cases.  
 
 
Conclusions: A daily peer review session is feasible and now 
a part of the normal practice in our Department. However, 
not all the patients are reviewed. There’s a need to re-
structure the peer review rounds so that a higher proportion 
of patients are reviewed. As most changes were on 
contouring we are considering creating a peer review round 
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focused on volume definition to be held before dose-
planning. To improve quality thresholds can be tighten and a 
goal for next year is to reduce the time for curative patients 
to 12 days and to palliative patients to 3. 
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Purpose/Objective: The aim of the study is to develop 
proper quality indexes to increase the control on the 
workflow in radiotherapy by a quantitative analysis of data 
extracted from the R&V system database of our radiotherapy 
department 
Materials and Methods: Several technical parameters related 
to delivery modality (3D CRT or VMAT), use of flattened (FF) 
or unflattened (FFF) beams, pre treatment imaging and other 
planning details were extracted for each patient by proper 
SQL querying of the database. These features were analyzed 
to derive indicators for radiotherapy treatment quality and 
workflow monitoring. Introduction of new clinical protocols 
of hypofrationated treatments was quantified by considering 
the incidence of standard fraction doses up to 3 Gy per 
fraction against higher fractionation schemes. Couch shifts 
between laser-based patient positioning and IGRT setup were 
evaluated for all IMRT/VMAT hypofractionated breast 
treatments as a tool to sistematically take isocenter accuracy 
under control 
Results: Data since 2003 show an increasing average trend in 
the number of new patients treated per year at our centre 
(up to 2500 in 2013). Data show a significant increment of 
technological innovation starting from 2010 when IMRT 
(mostly rapidarc) have been introduced. The fraction of 
rapidarc treatments was about 20% in 2010 up to a proportion 
of about 75% at the end of 2013. Since 2010, average 
treatment Beam On Time (BOT) resulted in a significant 
decrease for high fraction doses up to a value of about 2 
minutes found in 2013 for every treatment, regardless the 
adopted fractionation and technique (Fig 1A). This result was 
achieved due to the availability of FFF high dose rate beams 
in linear accelerators (presently used in about 90% of cases 
for fraction doses above 4Gy) coupled with use of the VMAT 
technique available since 2010 in our centre. In the last 5 
years, use of hypofractionation has grown from 16% to about 
40% of treatments(Fig 1B). The incidence of pre treatment 
imaging was evaluated as a workflow indicator for treatments 
on all machines and patients: data for 2013 showed that IGRT 
was applied to more than 80% of treatments in all therapy 
sessions and always performed in the first fraction for all 
patients. Evaluation of couch shifts for complex breast 
treatments was found to be on average below 5 mm as vector 
modulus. 
 
 
Fig1 A) Average BOT according to different fractionations B) 
fractionation over time 
 
Conclusions: The evolution of technology in a radiotherapy 
department was quantified and evaluated by means of a data 
mining of treatment records since 2003.The introduction of 
new protocols coupled to a growing complexity of treatments 
led to higher doses per fraction without increasing BOT for a 
better patient overall comfort. The evaluation of patient 
positioning and IGRT monitoring using our indicators was 
found to be suitable to obtain high quality standards in 
essential parts of the radiotherapy workflow in our center. 
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Purpose/Objective: Radiotherapy is indicated in at least 48% 
of cancer treatments1,4 and is recognised as an extremely 
cost-effective treatment option for low and middle income 
countries4. And yet of 139 LMIC countries 55 have no access 
to RT at all, and 80 have only minimal treatment facilities 
available6. It has been recognised by the IAEA5 that the high 
capital cost and complex technological delivery of 
conventional X-ray radiotherapy systems is a major barrier 
preventing an estimated 4 million cancer sufferers worldwide 
